Developmental Milestones for Children With Down Syndrome.

IF 6.2 2区 医学 Q1 PEDIATRICS Pediatrics Pub Date : 2024-10-01 DOI:10.1542/peds.2023-065402
Nicole Baumer, Rafael DePillis, Katherine Pawlowski, Bo Zhang, Maitreyi Mazumdar
{"title":"Developmental Milestones for Children With Down Syndrome.","authors":"Nicole Baumer, Rafael DePillis, Katherine Pawlowski, Bo Zhang, Maitreyi Mazumdar","doi":"10.1542/peds.2023-065402","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The American Academy of Pediatrics recommends that children and adolescents with Down syndrome receive anticipatory guidance regarding development and behavior. However, few tools provide specific guidance on developmental norms for children with Down syndrome. Our objective was to estimate age ranges at which children and adolescents with Down syndrome achieve developmental milestones to facilitate developmental screening by pediatric practitioners.</p><p><strong>Methods: </strong>We used standardized questionnaires to obtain information from clinicians and caregivers of children with Down syndrome who received care at the Boston Children's Hospital Down Syndrome Program between March 2018 and March 2023. Data included information from 2599 visits for 842 individuals with Down syndrome ages 2 months to 24 years. We used mixed-effects logistic regressions to predict the probability of achieving 25 specific developmental milestones with 15%, 30%, 45%, 60%, 75%, and 90% probability as a function of age. We further stratified results by individuals' sex.</p><p><strong>Results: </strong>We present age norms for our study's population of people with Down syndrome for key milestones in academic, adaptive, language, and motor domains by calculating the ages at which milestone achievement was 75% probable. We then compare these norms to published norms for the general population.</p><p><strong>Conclusions: </strong>This study provides clinicians and families with age-based norms for achievement of key developmental milestones for children and adolescents with Down syndrome.</p>","PeriodicalId":20028,"journal":{"name":"Pediatrics","volume":null,"pages":null},"PeriodicalIF":6.2000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatrics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1542/peds.2023-065402","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: The American Academy of Pediatrics recommends that children and adolescents with Down syndrome receive anticipatory guidance regarding development and behavior. However, few tools provide specific guidance on developmental norms for children with Down syndrome. Our objective was to estimate age ranges at which children and adolescents with Down syndrome achieve developmental milestones to facilitate developmental screening by pediatric practitioners.

Methods: We used standardized questionnaires to obtain information from clinicians and caregivers of children with Down syndrome who received care at the Boston Children's Hospital Down Syndrome Program between March 2018 and March 2023. Data included information from 2599 visits for 842 individuals with Down syndrome ages 2 months to 24 years. We used mixed-effects logistic regressions to predict the probability of achieving 25 specific developmental milestones with 15%, 30%, 45%, 60%, 75%, and 90% probability as a function of age. We further stratified results by individuals' sex.

Results: We present age norms for our study's population of people with Down syndrome for key milestones in academic, adaptive, language, and motor domains by calculating the ages at which milestone achievement was 75% probable. We then compare these norms to published norms for the general population.

Conclusions: This study provides clinicians and families with age-based norms for achievement of key developmental milestones for children and adolescents with Down syndrome.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
唐氏综合症儿童的发育里程碑。
目标:美国儿科学会建议患有唐氏综合症的儿童和青少年接受有关发育和行为的预期指导。然而,很少有工具能为唐氏综合症儿童的发育标准提供具体指导。我们的目标是估计唐氏综合症儿童和青少年达到发育里程碑的年龄范围,以方便儿科医生进行发育筛查:我们使用标准化问卷,从临床医生和唐氏综合征患儿护理人员处获取信息,这些患儿在 2018 年 3 月至 2023 年 3 月期间接受了波士顿儿童医院唐氏综合征项目的治疗。数据包括 842 名 2 个月至 24 岁唐氏综合征患儿的 2599 次就诊信息。我们使用混合效应逻辑回归法预测了实现 25 个特定发育里程碑的概率,其与年龄的函数关系分别为 15%、30%、45%、60%、75% 和 90%。我们还根据个体的性别对结果进行了分层:我们通过计算有 75% 可能性实现里程碑的年龄,为我们研究的唐氏综合症患者群体提供了学习、适应、语言和运动领域关键里程碑的年龄标准。然后,我们将这些标准与已公布的普通人群标准进行比较:这项研究为临床医生和家庭提供了基于年龄的唐氏综合症儿童和青少年关键发育里程碑的达标标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Pediatrics
Pediatrics 医学-小儿科
CiteScore
12.80
自引率
5.00%
发文量
791
审稿时长
2-3 weeks
期刊介绍: The Pediatrics® journal is the official flagship journal of the American Academy of Pediatrics (AAP). It is widely cited in the field of pediatric medicine and is recognized as the leading journal in the field. The journal publishes original research and evidence-based articles, which provide authoritative information to help readers stay up-to-date with the latest developments in pediatric medicine. The content is peer-reviewed and undergoes rigorous evaluation to ensure its quality and reliability. Pediatrics also serves as a valuable resource for conducting new research studies and supporting education and training activities in the field of pediatrics. It aims to enhance the quality of pediatric outpatient and inpatient care by disseminating valuable knowledge and insights. As of 2023, Pediatrics has an impressive Journal Impact Factor (IF) Score of 8.0. The IF is a measure of a journal's influence and importance in the scientific community, with higher scores indicating a greater impact. This score reflects the significance and reach of the research published in Pediatrics, further establishing its prominence in the field of pediatric medicine.
期刊最新文献
Prophylaxis Options in Children With a History of Recurrent Urinary Tract Infections: A Systematic Review. Recurrent Urinary Tract Infection Prevention: Progress and Challenges. Rett Syndrome and the Broader Implications of the Use of Eponyms in Medicine. RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing. ECMO Survivors' Reflections on Their ICU Experience and Recovery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1